1. Oxford-MEST classification in IgA nephropathy patients: A report from Iran

Hamid Nasri*, Mojgan Mortazavi, Ali Ghorbani, Heshmatollah Shahbazian, Soleiman Kheiri, Azar Baradaran, Afsoon Emami-Naieni, Maryam Saffari, Saeed Mardani, Ali Momeni, Yahya Madihi, Milad Baradaran-Ghahfarokhi, Mahmoud Rafieian-Kopaie, Parin Hedayati, Shahzad Baradaran, Mohammadreza Ardalan, Shahram Sajjadieh, Naziheh Assarzadegan, Seyed Mohammad Ahmadi Soleimani, Mohamad Reza Tamadon

J Nephropathol. 2012;1(1): 31-42. doi: 10.5812/jnp.7

PMCID: PMC3886168 PMID: 24475384 Scopus ID: 84867271251

Article

PDF

XML

Cited By:

Original Article

2. Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial

Fatemeh Hayati, Heshmatollah Shahbazian, Ali Ghorbani, Shahla Ahmadi Halili*, Eisa Rezaei, Leila Sabetnia, Seyed Seifollah Beladi Mousavi

J Nephropathol. 2019;8(2): e12. doi: 10.15171/jnp.2019.12

Scopus ID: 85065879302

Article

PDF

XML

Cited By:

Original Article

3. Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobulin and standard therapy in kidney transplantation; a randomized double-blind clinical trial

Heshmatollah Shahbazian , Ali Ghorbani, Fatemeh Hayati, Seyed Seifollah Beladi Mousavi , Leila Sabetnia* , Shahla Ahmadi Halili, Shokouh Shayanpour , Isa Rezaee

J Nephropathol. 2020;9(1): e08. doi: 10.15171/jnp.2020.08

Scopus ID: 85078280329

Article

PDF

XML

Cited By: